BioSpace News Archive

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and AiCure, an AI and advanced data analytics company, today announced a novel strategic partnership to drive faster, smarter trials to optimize patient engagement.

HCI College, a south Florida-based leader in nursing and first responder education, announced that Pedro C. De Guzman has been named President and Chief Executive Officer, effective immediately.

INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal Culture System, today announced it has entered into commercialization agreements in Eurasia, covering Turkey and Jordan.

Skyhawk Therapeutics, Inc. (Skyhawk) today announced that it has entered into a second global strategic collaboration with an affiliate of Celgene Corporation (NASDAQ: CELG).

The Marburg virus vaccine candidate, licensed by IAVI from the Public Health Agency of Canada, demonstrated strong protection from the deadly disease in non-human primate studies.

Afya collected the estimates between November 1 and November 11, 2019, directly from the analysts, who normalized their estimates for comparability in terms of the impact of IFRS 16.

Anthem ranked seventh on the list, and was the highest-ranked company in the health care providers category.

Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at two upcoming investor healthcare conferences.

Solera, the nation’s leading network of digital and community health partners, today announced its expanded relationship with Blue Mesa Health.

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today announced initiation of a Phase 1/2 clinical study of its lead drug candidate repotrectinib in pediatric patients with ALK-, NTRK- and ROS1-positive solid tumors.